12 June 2020
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful
SYNLAB Bondco PLC
Post-Stabilisation Notice
Pursuant to Article 6(3) of Commission Delegated Regulation (EU) 2016/1052 supplementing Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation, Deutsche Bank AG, London Branch (contact: Diarmuid Toomey, telephone +44 (0)207 5454726) hereby gives notice that no stabilisation was undertaken by the Stabilising Manager named below in relation to the offer of the following securities.
Issuer: SYNLAB Bondco PLC
Guarantors (if any): Institut für medizinische und chemische Labordiagnostik Gesellschaft m.b.H., SYNLAB Holding Austria GmbH, SYNLAB Belgium SC SPRL, Labco UK Group Limited, SYNLAB Analytics & Services United Kingdom Limited, SYNLAB Aquitaine, SYNLAB Biofrance, SYNLAB Corporate Assistance, SYNLAB France SAS, SYNLAB Hauts De France, SYNLAB Holding France SA, SYNLAB Nord de France, SYNLAB Oxabio, SYNLAB Provence, MVZ SYNLAB Leverkusen GmbH, Steinlach-Klinik GmbH, SYNLAB Acquisition GmbH, SYNLAB Analytics & Services Germany GmbH, SYNLAB Holding Deutschland GmbH, SYNLAB International GmbH, SYNLAB Medizinisches Versorgungszentrum Augsburg GmbH, SYNLAB Medizinisches Versorgungszentrum Berlin GmbH, SYNLAB Medizinisches Versorgungszentrum Heidelberg GmbH, SYNLAB Medizinisches Versorgungszentrum Humangenetik Mannheim GmbH, SYNLAB Medizinisches Versorgungszentrum Kassel GmbH, SYNLAB Medizinisches Versorgungszentrum Leinfelden-Echterdingen GmbH, SYNLAB Medizinisches Versorgungszentrum Stuttgart GmbH, SYNLAB Medizinisches Versorgungszentrum Trier GmbH, SYNLAB Medizinisches Versorgungszentrum Weiden GmbH, SYNLAB Verwaltungs- und Beteiligungs GmbH, SYNLAB.vet GmbH, Istituto il Baluardo SpA, S.D.N. SpA, SYNLAB Holding Italy S.R.L., SYNLAB Italia S.R.L., SYNLAB Analytics & Services B.V., SYNLAB Analytics & Services Oosterhout B.V., SYNLAB Diagnosticos Globales, S.A. Sociedad Unipersonal, SYNLAB Holding Iberia, S.A., SYNLAB Analytics & Services Sweden AB and SYNLAB Suisse SA
Aggregate nominal amount: €850 million
Description: EUR850m, Senior Secured Floating Rate Notes, E+4.75% Coupon due July 2025 (RegS ISIN: XS2170852763, 144A ISIN: XS2170852847)
Issue/Reoffer Price: 99.00
Spread over benchmark: n.a.
Stabilising Manager(s): Deutsche Bank AG, London Branch
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.